Skip to main content
. 2022 Mar 16;27(5):e406–e409. doi: 10.1093/oncolo/oyac037

Figure 1.

Figure 1.

Spectrum of genomic alterations detected by ctDNA pre- and post-immune checkpoint inhibitor therapy, stratified by response to therapy (each column represents an individual patient and numbers indicate the total number of variants for a given gene in an individual patient). ctDNA, circulating tumor DNA.